Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...
Cystic fibrosis is a life-threatening genetic disease that causes severe damage to the lungs. Ivacaftor, the first drug that targeted the underlying defect of the disease caused by specific mutations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results